Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 14, 2015; 21(14): 4358-4364
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4358
Figure 1
Figure 1 Flow diagram for studies evaluating S-1 vs capecitabine for gastric cancer included in this meta-analysis.
Figure 2
Figure 2 One year survival rate of S-1 regiment vs capecitabine regiment.
Figure 3
Figure 3 Overall response rate of S-1 regiment vs capecitabine regiment.
Figure 4
Figure 4 Nausea of S-1 regiment vs capecitabine regiment.
Figure 5
Figure 5 Toxicity of S-1 regiment vs capecitabine regiment.
Figure 6
Figure 6 Publication bias assessed by funnel plot.